We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
PUT
Cleveland-Cliffs
CLF
$6.57B
| $393K | 0.01% |
+5,000
| New | +$26.6K |
|
702
SLB Ltd
SLB
$73.6B
| $391K | 0.01% |
4,540
-141,303
| -97% | -$12.8M |
|
703
Southern Company
SO
$109B
| $388K | 0.01% |
9,267
-2,433
| -21% | -$106K |
|
|
HMHC
704
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $388K | 0.01% |
+15,392
| New | +$382K |
|
705
Douglas Emmett
DEI
$1.98B
| $387K | 0.01% |
+14,369
| New | +$416K |
|
706
NCR Voyix
VYX
$1.14B
| $387K | 0.01% |
20,931
+1,638
| +8% | +$30.3K |
|
707
Live Nation Entertainment
LYV
$40.6B
| $384K | 0.01% |
+13,952
| New | +$381K |
|
708
Eagle Materials
EXP
$6.29B
| $383K | 0.01% |
+5,013
| New | +$414K |
|
709
United Therapeutics
UTHR
$25.8B
| $383K | 0.01% |
2,200
-600
| -21% | -$108K |
|
|
FITB
710
Fifth Third Bancorp
FITB
$51.2B
| $381K | 0.01% |
18,285
-196,055
| -91% | -$3.97M |
|
|
CXP
711
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $377K | 0.01% |
15,347
+2,847
| +23% | +$75.2K |
|
|
CBL
712
DELISTED
CBL& Associates Properties, Inc.
CBL
| $376K | 0.01% |
+23,231
| New | +$419K |
|
713
BorgWarner
BWA
$13.1B
| $375K | 0.01% |
7,498
-82,344
| -92% | -$4.39M |
|
714
Starwood Property Trust
STWD
$5.92B
| $375K | 0.01% |
+17,373
| New | +$412K |
|
715
Waters Corp
WAT
$37B
| $375K | 0.01% |
2,922
-69,388
| -96% | -$9M |
|
716
Republic Services
RSG
$64.8B
| $372K | 0.01% |
9,507
-525
| -5% | -$21.1K |
|
717
Arrow Electronics
ARW
$11.1B
| $371K | 0.01% |
+6,654
| New | +$404K |
|
|
DRC
718
DELISTED
DRESSER-RAND GROUP INC
DRC
| $371K | 0.01% |
4,355
-126,530
| -97% | -$10.6M |
|
719
Goodyear
GT
$2B
| $370K | 0.01% |
12,282
-317,021
| -96% | -$9.42M |
|
|
AVP
720
PUT
DELISTED
Avon Products, Inc.
AVP
| $370K | 0.01% |
4,000
| – | – |
|
721
Monster Beverage
MNST
$94.3B
| $369K | 0.01% |
+16,536
| New | +$369K |
|
722
PBF Energy
PBF
$8.57B
| $369K | 0.01% |
+12,992
| New | +$365K |
|
723
Lowe's Companies
LOW
$117B
| $368K | 0.01% |
5,501
-1,939
| -26% | -$138K |
|
724
Howard Hughes
HHH
$3.81B
| $367K | 0.01% |
+2,680
| New | +$381K |
|
725
Sabesp
SBS
$19.1B
| $365K | 0.01% |
+363,612
| New | +$409K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.